Last Call for September 19th PBM Reform Webinar!

Register Now – Assessing the Congressional Landscape for Drug Cost Containment: Legislative and Policy Considerations in the context of Pharmacy Benefit Manager (PBM) Reforms

Webinar | Tuesday, September 19, 2023, 2:00pm EST

Join us to hear from the Public Sector HealthCare Roundtable’s senior policy team and policy experts on the hot topic issue of PBMs and how these policies relate to public sector purchasers, an analysis of the evolving legislative landscape, and a lens on crucial considerations as the current year draws to a close and anticipation builds for the year ahead in 2024.

Polly Webster

Polly Webster

Senior Counsel, Health, U.S. Senate Finance Committee 

Polly Webster is the Senior Counsel, Health for the Democratic for Senate Finance Committee. Polly has expertise in prescription drug policy, experience working in the House and Senate, and the ability to work collaboratively across a diverse set of stakeholders.

Prior to serving the Senate Finance Committee, Polly worked at the Association for Accessible Medicine (AAM) as Vice President of Federal Affairs. In this role, Polly advocated on behalf of AAM’s interests to congressional leaders and the White House. Previously to joining AAM, Polly was the Principal Policy Advisor, Government Relations for Kaiser Permanente, where she led the organization’s work on prescription drug policy and regulations. Polly also served as Health Policy Director for Congresswoman Diana DeGette (D-CO), Health Policy Fellow on the Democratic Senate Committee on Finance and with Senator Jay Rockefeller (D-WV).

Polly received her Bachelor’s Degree from Denison University, her Master of Public Health from George Washington University, and her Law degree from Georgetown University.

Jennifer Wagner

Jennifer Wagner

Director, Public and Government Affairs

Jennifer plays an important role in advancing RxSS’ government policy and business development efforts aimed at delivery system transformation and transparency into prescription drug costs.

She came to RxSS in 2022 from Business Group on Health where she spent nearly 8 years advocating for large, self-insured employers on health policy issues and specifically led the Pharmacy Benefit Committee, an advanced cohort of employers and key industry leaders with a mission of ensuring the sustainability of employer-sponsored pharmacy benefits.

Jennifer received her Bachelor’s Degree from George Washington University, and her Master of Public Health from Yale School of Public Health.

Andrew MacPherson

Andrew MacPherson Senior Policy Advisor

Public Sector HealthCare Roundtable

Andrew is a Founding Principal and Managing Partner at Healthsperien, LLC, with two decades of federal and state health care legislative and regulatory policy and political experience.

As Managing Partner, Andrew co-leads a team of over forty experts who specialize in developing comprehensive legislative and regulatory policy strategies, in-depth analyses, and strategic advocacy and communications initiatives for a wide-range of health care organizations, including Fortune 100 businesses, public sector purchasers, national health plans, professional associations, issue-based coalitions, health care start-ups and market innovators, and not-for-profit providers.

Andrew has a special emphasis and speaks regularly to national audiences on policy and political issues related to person-centered health care delivery transformation, including the public health crisis of social isolation and loneliness in the U.S., value-based insurance design (V-BID), and person-centered advanced illness and end-of-life care delivery. To read more, click here.

Webinar Summary

The persistent challenges surrounding pharmacy benefit manager reforms (PBM) have garnered significant Congressional attention on a bipartisan basis, and the Roundtable has played an active role in the debate. Before Congress adjourned for the August recess, the Senate Finance Committee (SFC) conducted a bipartisan markup session on the Modernizing and Ensuring PBM Accountability (MEPA) Act, which culminated to its passage out of committee. Without question, the next several months will be a critically important time where Congress will determine potentially major changes to the PBM marketplace.

This webinar is being produced in conjunction with Roundtable corporate member Rx Savings Solutions.

 

Register Here 

For more information about Public Sector HealthCare Roundtable policy priorities and activities, please visit:

www.healthcareroundtable.us